MediFind
Condition

Juvenile Temporal Arteritis

Latest Research

Latest Advance
Study
  • Condition: Aortitis Disease
  • Journal: The heart surgery forum
  • Treatment Used: Aortic Valve Surgery
  • Number of Patients: 15
  • Published —
The study researched the outcomes of aortic valve surgery in patients with aortitis disease.
Latest Advance
Study
  • Condition: Glucocorticoid Resistant Refractory Giant Cell Arteritis
  • Journal: BMJ case reports
  • Treatment Used: intravenous tocilizumab
  • Number of Patients: 1
  • Published —
The purpose of the study was to report a case of a patient with glucocorticoid resistant refractory giant cell arteritis treated with intravenous tocilizumab.
Latest Advance
Study
  • Condition: Large-vessel vasculitis giant cell arteritis (GCA) and Takayasu arteritis (TA)
  • Journal: Der Internist
  • Treatment Used: Tocilizumab (TCZ)
  • Number of Patients: 0
  • Published —
This study described the necessary diagnostic testing and rapid treatment approaches for patients diagnosed with large-vessel vasculitis -- giant cell arteritis (GCA) and Takayasu arteritis (TA) --
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: Seminars in arthritis and rheumatism
  • Treatment Used: Tocilizumab
  • Number of Patients: 134
  • Published —
This study tested the safety and efficacy of using tocilizumab to treat patients with giant cell arteritis.
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: Clinical rheumatology
  • Treatment Used: Leflunomide
  • Number of Patients: 76
  • Published —
This study evaluated the effectiveness of leflunomide (anti-rheumatic drug) in patients with Giant Cell Arteritis (GCA; inflammatory condition that affects the blood vessels).
Latest Advance
Study
  • Condition: Giant cell arteritis
  • Journal: European journal of internal medicine
  • Treatment Used: Tocilizumab as an add-on therapy to glucocorticoids
  • Number of Patients: 20
  • Published —
This study evaluated the effects of tocilizumab as an add-on therapy to glucocorticoids during the first three months of treatment for giant cell arteritis.
Latest Advance
Study
  • Condition: Refractory Giant Cell Arteritis
  • Journal: Seminars in arthritis and rheumatism
  • Treatment Used: Ustekinumab
  • Number of Patients: 25
  • Published —
This study tested the safety and efficacy of using ustekinumab to treat patients with refractory giant cell arteritis.
Latest Advance
Study
  • Condition: Giant cell arteritis
  • Journal: Seminars in arthritis and rheumatism
  • Treatment Used: Toxilizumab, intravenous glucocorticoid (GC), and methotrexate
  • Number of Patients: 645
  • Published —
This extensive review of literature evaluated the body of literature by using the fragility index (FI) which measures the minimum number of patients with giant cell arteritis who might have a changed outcomes when receiving glucocorticoid (GC) sparing strategies. Ten studies were included.
Latest Advance
Study
  • Condition: Giant cell arteritis
  • Journal: Angiology
  • Treatment Used: Tocilizumab
  • Number of Patients: 12
  • Published —
This study evaluated the safety and efficacy of tocilizumab in patients with giant cell arteritis.